HOLLYANN PERRY: Open Payments
NPI 1316680309 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 10 companies in 2025. Trend: 2023 $247 · 2024 $154 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| Becton, Dickinson and Company | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| AtriCure, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| CVRx, Inc. | 1 | $16 |
Products named: LEQVIO, Venclose Maven Catheter, ELIQUIS, SYNERGY ABLATION SYSTEM, Ozempic, FARXIGA, NEXLETOL, VERQUVO.
Industry payments across FL — which companies pay providers there.
